Cargando…

Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up

PURPOSE: Lymphedema is a debilitating condition that significantly affects patient’s quality of life (QoL). The aim of this study was to assess the long-term outcomes after lymphaticovenous anastomosis (LVA) for extremity lymphedema. METHODS: A single-center prospective study on upper and lower extr...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Shan S., Pruimboom, Tim, Cornelissen, Anouk J. M., Schols, Rutger M., van Kuijk, Sander M. J., van der Hulst, René R. W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568701/
https://www.ncbi.nlm.nih.gov/pubmed/32767202
http://dx.doi.org/10.1007/s10549-020-05839-4
_version_ 1783596577911209984
author Qiu, Shan S.
Pruimboom, Tim
Cornelissen, Anouk J. M.
Schols, Rutger M.
van Kuijk, Sander M. J.
van der Hulst, René R. W. J.
author_facet Qiu, Shan S.
Pruimboom, Tim
Cornelissen, Anouk J. M.
Schols, Rutger M.
van Kuijk, Sander M. J.
van der Hulst, René R. W. J.
author_sort Qiu, Shan S.
collection PubMed
description PURPOSE: Lymphedema is a debilitating condition that significantly affects patient’s quality of life (QoL). The aim of this study was to assess the long-term outcomes after lymphaticovenous anastomosis (LVA) for extremity lymphedema. METHODS: A single-center prospective study on upper and lower extremity lymphedema patients was performed. All LVA procedures were preceded by outpatient Indocyanine Green (ICG) lymphography. Quality of life measured by the Lymph-ICF was the primary outcome. Limb circumference, use of compression garments, and frequency of cellulitis episodes and manual lymphatic drainage (MLD) sessions were secondary outcomes. RESULTS: One hundred consecutive patients, predominantly experiencing upper extremity lymphedema following breast cancer (n = 85), underwent a total of 132 LVAs. During a mean follow-up of 25 months, mean Lymph-ICF score significantly decreased from 43.9 preoperative to 30.6 postoperative, representing significant QoL improvement. Decrease in upper and lower limb circumference was observed in 52% of patients with a mean decrease of 6%. Overall mean circumference was not significantly different. Percentage of patients that could reduce compression garments in the upper and lower extremity group was 65% and 40%, respectively. Number of cellulitis episodes per year and MLD sessions per week showed a mean decrease of respectively 0.6 and 0.8 in the upper extremity and 0.4 and 1.0 in the lower extremity group. CONCLUSIONS: LVA resulted in significant QoL improvement in upper and lower extremity lymphedema patients. Limb circumference did not significantly improve but good results concerning compression garments, cellulitis episodes, and MLD sessions were obtained. Additionally, a simple and patient-friendly method for outpatient ICG lymphography is presented.
format Online
Article
Text
id pubmed-7568701
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-75687012020-10-19 Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up Qiu, Shan S. Pruimboom, Tim Cornelissen, Anouk J. M. Schols, Rutger M. van Kuijk, Sander M. J. van der Hulst, René R. W. J. Breast Cancer Res Treat Clinical Trial PURPOSE: Lymphedema is a debilitating condition that significantly affects patient’s quality of life (QoL). The aim of this study was to assess the long-term outcomes after lymphaticovenous anastomosis (LVA) for extremity lymphedema. METHODS: A single-center prospective study on upper and lower extremity lymphedema patients was performed. All LVA procedures were preceded by outpatient Indocyanine Green (ICG) lymphography. Quality of life measured by the Lymph-ICF was the primary outcome. Limb circumference, use of compression garments, and frequency of cellulitis episodes and manual lymphatic drainage (MLD) sessions were secondary outcomes. RESULTS: One hundred consecutive patients, predominantly experiencing upper extremity lymphedema following breast cancer (n = 85), underwent a total of 132 LVAs. During a mean follow-up of 25 months, mean Lymph-ICF score significantly decreased from 43.9 preoperative to 30.6 postoperative, representing significant QoL improvement. Decrease in upper and lower limb circumference was observed in 52% of patients with a mean decrease of 6%. Overall mean circumference was not significantly different. Percentage of patients that could reduce compression garments in the upper and lower extremity group was 65% and 40%, respectively. Number of cellulitis episodes per year and MLD sessions per week showed a mean decrease of respectively 0.6 and 0.8 in the upper extremity and 0.4 and 1.0 in the lower extremity group. CONCLUSIONS: LVA resulted in significant QoL improvement in upper and lower extremity lymphedema patients. Limb circumference did not significantly improve but good results concerning compression garments, cellulitis episodes, and MLD sessions were obtained. Additionally, a simple and patient-friendly method for outpatient ICG lymphography is presented. Springer US 2020-08-07 2020 /pmc/articles/PMC7568701/ /pubmed/32767202 http://dx.doi.org/10.1007/s10549-020-05839-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Trial
Qiu, Shan S.
Pruimboom, Tim
Cornelissen, Anouk J. M.
Schols, Rutger M.
van Kuijk, Sander M. J.
van der Hulst, René R. W. J.
Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up
title Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up
title_full Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up
title_fullStr Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up
title_full_unstemmed Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up
title_short Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up
title_sort outcomes following lymphaticovenous anastomosis (lva) for 100 cases of lymphedema: results over 24-months follow-up
topic Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568701/
https://www.ncbi.nlm.nih.gov/pubmed/32767202
http://dx.doi.org/10.1007/s10549-020-05839-4
work_keys_str_mv AT qiushans outcomesfollowinglymphaticovenousanastomosislvafor100casesoflymphedemaresultsover24monthsfollowup
AT pruimboomtim outcomesfollowinglymphaticovenousanastomosislvafor100casesoflymphedemaresultsover24monthsfollowup
AT cornelissenanoukjm outcomesfollowinglymphaticovenousanastomosislvafor100casesoflymphedemaresultsover24monthsfollowup
AT scholsrutgerm outcomesfollowinglymphaticovenousanastomosislvafor100casesoflymphedemaresultsover24monthsfollowup
AT vankuijksandermj outcomesfollowinglymphaticovenousanastomosislvafor100casesoflymphedemaresultsover24monthsfollowup
AT vanderhulstrenerwj outcomesfollowinglymphaticovenousanastomosislvafor100casesoflymphedemaresultsover24monthsfollowup